Madrigal Pharmaceuticals, Inc. (MDGL): Depreciation & Amortization
$1.51M
Year ended 2025-12-31
$1.52M
Trailing 12 months to 2026-06-30
+47.7%
3-year compound annual growth
+26.2%
5-year compound annual growth
+8.6%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.51M | +37.4% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $1.10M | +108.0% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $527.0K | +12.8% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $467.0K | +15.3% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $405.0K | -14.0% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $471.0K | +320.5% | 2023-03-03, From 2020-01-01 |
| 2019-12-31 | $112.0K | +16.7% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $96.0K | +24.7% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $77.0K | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $156 | -100.0% | 2017-03-31, From 2016-01-01 |
| 2015-12-31 | $662.0K | -1.6% | 2016-03-15, From 2015-01-01 |
| 2014-12-31 | $673.0K | +30.4% | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | $516.0K | -30.1% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $738.0K | -49.6% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $1.46M | -24.3% | 2014-03-11, From 2011-01-01 |
| 2010-12-31 | $1.93M | -21.5% | 2013-03-14, From 2010-01-01 |
| 2009-12-31 | $2.46M | n/a | 2012-02-22, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.51M | +37.4% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $91.42M | +35.0% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $31.27M | +3.6% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.20M | +31.4% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $1.15M | +44.5% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $95.80M | -11.9% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $10.00M | -37.5% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $91.02M | +15.5% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $91.56M | +13.9% |
Compare MDGL, ANIP, PBH, ARWR side by side · Screen every company in Pharmaceutical Preparations ↗